vs
Royalty Pharma plc（RPRX）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
RANGE RESOURCES CORP的季度营收约是Royalty Pharma plc的1.3倍（$786.9M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 22.8%，领先11.7%），RANGE RESOURCES CORP同比增速更快（18.0% vs 4.8%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs 4.6%）
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
RPRX vs RRC — 直观对比
营收规模更大
RRC
是对方的1.3倍
$622.0M
营收增速更快
RRC
高出13.2%
4.8%
净利率更高
RPRX
高出11.7%
22.8%
两年增速更快
RRC
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $622.0M | $786.9M |
| 净利润 | $214.2M | $179.1M |
| 毛利率 | — | 94.5% |
| 营业利润率 | 62.4% | — |
| 净利率 | 34.4% | 22.8% |
| 营收同比 | 4.8% | 18.0% |
| 净利润同比 | 2.9% | 88.8% |
| 每股收益（稀释后） | $0.49 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RPRXRRC
| Q4 25 | $622.0M | $786.9M | ||
| Q3 25 | $609.3M | $655.3M | ||
| Q2 25 | $578.7M | $699.6M | ||
| Q1 25 | $568.2M | $846.3M | ||
| Q4 24 | $593.6M | $667.0M | ||
| Q3 24 | $564.7M | $567.9M | ||
| Q2 24 | $537.3M | $513.2M | ||
| Q1 24 | $568.0M | $598.8M |
净利润RPRXRRC
| Q4 25 | $214.2M | $179.1M | ||
| Q3 25 | $288.2M | $144.3M | ||
| Q2 25 | $30.2M | $237.6M | ||
| Q1 25 | $238.3M | $97.1M | ||
| Q4 24 | $208.2M | $94.8M | ||
| Q3 24 | $544.0M | $50.7M | ||
| Q2 24 | $102.0M | $28.7M | ||
| Q1 24 | $4.8M | $92.1M |
毛利率RPRXRRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | — | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | — | 93.7% | ||
| Q3 24 | — | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率RPRXRRC
| Q4 25 | 62.4% | — | ||
| Q3 25 | 70.1% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 94.0% | — | ||
| Q4 24 | 60.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 50.2% | — | ||
| Q1 24 | -13.0% | — |
净利率RPRXRRC
| Q4 25 | 34.4% | 22.8% | ||
| Q3 25 | 47.3% | 22.0% | ||
| Q2 25 | 5.2% | 34.0% | ||
| Q1 25 | 41.9% | 11.5% | ||
| Q4 24 | 35.1% | 14.2% | ||
| Q3 24 | 96.3% | 8.9% | ||
| Q2 24 | 19.0% | 5.6% | ||
| Q1 24 | 0.8% | 15.4% |
每股收益（稀释后）RPRXRRC
| Q4 25 | $0.49 | $0.75 | ||
| Q3 25 | $0.67 | $0.60 | ||
| Q2 25 | $0.07 | $0.99 | ||
| Q1 25 | $0.55 | $0.40 | ||
| Q4 24 | $0.46 | $0.38 | ||
| Q3 24 | $1.21 | $0.21 | ||
| Q2 24 | $0.23 | $0.12 | ||
| Q1 24 | $0.01 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $618.7M | $204.0K |
| 总债务越低越好 | $9.0B | $1.2B |
| 股东权益账面价值 | $9.7B | $4.3B |
| 总资产 | $19.6B | $7.4B |
| 负债/权益比越低杠杆越低 | 0.92× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资RPRXRRC
| Q4 25 | $618.7M | $204.0K | ||
| Q3 25 | $938.9M | $175.0K | ||
| Q2 25 | $631.9M | $134.0K | ||
| Q1 25 | $1.1B | $344.6M | ||
| Q4 24 | $929.0M | $304.5M | ||
| Q3 24 | $950.1M | $277.4M | ||
| Q2 24 | $1.8B | $251.1M | ||
| Q1 24 | $843.0M | $343.1M |
总债务RPRXRRC
| Q4 25 | $9.0B | $1.2B | ||
| Q3 25 | $8.9B | $1.2B | ||
| Q2 25 | $8.0B | $1.2B | ||
| Q1 25 | $7.6B | $1.7B | ||
| Q4 24 | $7.6B | $1.7B | ||
| Q3 24 | $7.6B | $1.7B | ||
| Q2 24 | $7.6B | $1.7B | ||
| Q1 24 | $6.1B | $1.8B |
股东权益RPRXRRC
| Q4 25 | $9.7B | $4.3B | ||
| Q3 25 | $9.6B | $4.2B | ||
| Q2 25 | $9.5B | $4.1B | ||
| Q1 25 | $9.8B | $3.9B | ||
| Q4 24 | $10.3B | $3.9B | ||
| Q3 24 | $10.3B | $3.9B | ||
| Q2 24 | $9.8B | $3.9B | ||
| Q1 24 | $9.9B | $3.8B |
总资产RPRXRRC
| Q4 25 | $19.6B | $7.4B | ||
| Q3 25 | $19.3B | $7.2B | ||
| Q2 25 | $18.3B | $7.1B | ||
| Q1 25 | $17.6B | $7.4B | ||
| Q4 24 | $18.2B | $7.3B | ||
| Q3 24 | $18.0B | $7.2B | ||
| Q2 24 | $17.7B | $7.3B | ||
| Q1 24 | $16.1B | $7.4B |
负债/权益比RPRXRRC
| Q4 25 | 0.92× | 0.28× | ||
| Q3 25 | 0.93× | 0.29× | ||
| Q2 25 | 0.84× | 0.29× | ||
| Q1 25 | 0.78× | 0.43× | ||
| Q4 24 | 0.74× | 0.43× | ||
| Q3 24 | 0.74× | 0.44× | ||
| Q2 24 | 0.78× | 0.44× | ||
| Q1 24 | 0.62× | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $827.1M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.86× | 1.44× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流RPRXRRC
| Q4 25 | $827.1M | $257.5M | ||
| Q3 25 | $702.6M | $247.5M | ||
| Q2 25 | $364.0M | $336.2M | ||
| Q1 25 | $596.1M | $330.1M | ||
| Q4 24 | $742.5M | $217.9M | ||
| Q3 24 | $703.6M | $245.9M | ||
| Q2 24 | $658.2M | $148.8M | ||
| Q1 24 | $664.6M | $331.9M |
现金转化率RPRXRRC
| Q4 25 | 3.86× | 1.44× | ||
| Q3 25 | 2.44× | 1.72× | ||
| Q2 25 | 12.06× | 1.42× | ||
| Q1 25 | 2.50× | 3.40× | ||
| Q4 24 | 3.57× | 2.30× | ||
| Q3 24 | 1.29× | 4.85× | ||
| Q2 24 | 6.45× | 5.18× | ||
| Q1 24 | 139.10× | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
